sorafenib has been researched along with Coronary Vasospasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, Y; Fukushima, H; Nakamura, S; Noda, K; Ogawa, H; Oshima, S; Shono, M; Taniguchi, I | 1 |
| Chen, CL; Naib, T; Steingart, RM | 1 |
2 other study(ies) available for sorafenib and Coronary Vasospasm
| Article | Year |
|---|---|
Sorafenib-induced acute myocardial infarction due to coronary artery spasm.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Coronary Vasospasm; Humans; Kidney Neoplasms; Male; Myocardial Infarction; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Sorafenib | 2009 |
Sorafenib-associated multivessel coronary artery vasospasm.
Topics: Antineoplastic Agents; Benzenesulfonates; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2011 |